Dr. Jonathan Schoeff

speaker

2,131 appearances 2 recordings 1 series first heard Jul 2026 last heard 28 Jul

Dr. Jonathan Schoeff’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months

Recordings per month over the last 12 months — 2 in all, peaking in Jul 2026 with 2.

newest first · ▶ plays the moment

So samoralin, in my clinical experience, has little to no effect on serum IGF-1 levels.

IGF-1, this is a really important thing to say,

If you can't measure or quantify something, it's real hard to prove that something is or isn't working.

So if you want to sell a product, pick something that can't be measured because who's going to tell you it didn't work?

Brilliant, right?

That's the fundamental issue.

But look at all the peptides, okay, that are on the market that do indeed work, that have been brought to market by big pharma.

The common thread is you can measure a difference.

There is a organism level effect.

Well, yes.

So the way we typically measure growth hormone levels is in the form of IGF-1, which is a byproduct.

It's a downstream effect.

It's much more stable in the bloodstream.

So I test your IGF-1 today.

I put you on a testamoralin protocol.

In six weeks, I test it again.

I expect it to be 100% to 150% higher.

So I can prove we went from here to here.

Now we can get into... Testamoralin?

Samorelin, nominal effect.

Showing 921–940 of 2,131 · page 47 of 107